Form 4: Milestone Scientific Director Neal Goldman Acquires Shares as Part of Annual Fee

Neal Goldman, a director at Milestone Scientific Inc., acquired 134,832 shares of common stock on August 28, 2024, as part of his annual director's fee.

Summary

• On August 28, 2024, Neal Goldman, a director of Milestone Scientific Inc., acquired 134,832 shares of the company's common stock.
• The acquisition was part of the annual fee paid to non-employee directors, valued at $120,000 and payable in restricted shares.
• The price per share was $0.89.
• Following the transaction, Goldman's direct ownership in Milestone Scientific Inc. increased to 1,905,858 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a standard director compensation practice, aligning director interests with shareholders through equity ownership.

Positives

• Director's equity ownership aligns interests with shareholders.

Future Outlook

The restricted shares vest over the next three quarters, indicating a continued relationship between the director and the company.

Industry Context

Director compensation in the form of equity is a common practice to align the interests of board members with those of shareholders. This filing reflects standard compensation practices.

Comparison to Industry Standards

• Director compensation packages vary widely across industries and company sizes.
• Equity-based compensation is a common practice, but the specific amount and vesting schedules are tailored to each company's circumstances.
• Comparing Milestone Scientific's director compensation to similar-sized companies in the medical device industry would provide a more detailed benchmark.

Stakeholder Impact

• Shareholders may view the director's increased equity stake positively, as it aligns interests.
• The company's equity structure is affected by the issuance of new shares.

Key Dates